Alzamend Neuro (ALZN) Share-based Compensation (2020 - 2026)
Alzamend Neuro (ALZN) recorded Share-based Compensation of $77,199 in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 79.9% from $42,902 a year earlier but down 87.6% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Share-based Compensation (2020 - 2026) Analysis & Trends
On a TTM basis, Alzamend Neuro's Share-based Compensation came in at $741,824 as of Jul 31, 2026, up 158.7% year-over-year; for FY2026 (ended Apr 30, 2026), it was $707,527, up 117.6% from FY2025.
- Annual Share-based Compensation has a five-year compound annual growth rate of -19.0% (FY2021 to FY2026).
- Across earlier fiscal years, Share-based Compensation came in at $325,108 in FY2025 (-66.0%), $955,633 in FY2024 (-73.3%), $3.58 million in FY2023 (-18.7%) and $4.41 million in FY2022 (+116.9%).
- Quarterly Share-based Compensation has ranged from $9,300 in fiscal Q3 2026 to $1.51 million in fiscal Q3 2023 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in two of the last eight quarters, with growth averaging 52.4%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 667.5% in fiscal Q4 2026, against a decline of 88.6% in fiscal Q3 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $623,811 (Q4 2026), $9,300 (Q3 2026) and $31,514 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Alzamend Neuro | 8.78 Mn | 8.78 Mn | - | 77,199.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 77,199.00 |
| Apr 30, 2026 | 623,811.00 |
| Jan 31, 2026 | 9,300.00 |
| Oct 31, 2025 | 31,514.00 |
| Jul 31, 2025 | 42,902.00 |
| Apr 30, 2025 | 81,277.00 |
| Jan 31, 2025 | 81,277.00 |
| Oct 31, 2024 | 81,277.00 |
| Jul 31, 2024 | 81,277.00 |
| Apr 30, 2024 | 81,277.00 |
| Jan 31, 2024 | 186,640.00 |
| Oct 31, 2023 | 318,336.00 |
| Jul 31, 2023 | 369,380.00 |
| Apr 30, 2023 | 491,326.00 |
| Jan 31, 2023 | 1.51 Mn |
| Oct 31, 2022 | 715,639.00 |
| Jul 31, 2022 | 867,338.00 |
| Apr 30, 2022 | 1.26 Mn |
| Jan 31, 2022 | 1.13 Mn |
| Oct 31, 2021 | 1.28 Mn |
API Access
Alzamend Neuro Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();